Development of fast dissolving oral film containing dexamethasone as an antiemetic medication: Clinical usefulness

International Journal of Pharmaceutics

Volumn 424, Issue 1-2, 2012, Pages 12-17

  Nishigaki, Minako ^a   Kawahara, Kana ^a   Nawa, Masahito ^b   Futamura, Manabu ^b   Nishimura, Misao ^c   Matsuura, Katsuhiko ^a   Kitaichi, Kiyoyuki ^a   Kawaguchi, Yoshihiro ^b   Tsukioka, Tadao ^c   Yoshida, Kazuhiro ^b   Itoh, Yoshinori ^a  

^a GIFU UNIVERSITY HOSPITAL   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c Tsukioka Co Ltd   (Japan)

Author keywords

Antiemetic effect; Breast cancer patients; Dexamethasone; Fast dissolving oral film; Highly emetogenic chemotherapy

Indexed keywords

ANTHRACYCLINE; APREPITANT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; EPIRUBICIN; GRANISETRON; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL; MICROCRYSTALLINE CELLULOSE; POLYSORBATE 80;

ANTIEMETIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG SOLUBILITY; FILM COATING; HUMAN; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TABLET; VOMITING;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIEMETICS; BREAST NEOPLASMS; CROSS-OVER STUDIES; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOSAGE FORMS; DRUG THERAPY, COMBINATION; EPIRUBICIN; FEMALE; HUMANS; MIDDLE AGED; NAUSEA; VOMITING;

EID: 84856949486     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.12.057     Document Type: Article

References (22)

1. K. Al-Hezaimi, M. Al-Askar, Z. Selamhe, J.H. Fu, I.A. Alsarra, and H.L. Wang Evaluation of novel adhesive film containing ketorolac for post-surgery pain control: a safety and efficacy study J. Periodontol. 82 2011 963 968
2. E. Basch, A.A. Prestrud, P.J. Hesketh, M.G. Kris, P.C. Feyer, M.R. Somerfield, M. Chesney, R.A. Clark-Snow, A.M. Flaherty, B. Freundlich, G. Morrow, K.V. Rao, R.N. Schwartz, and G.H. Lyman Antiemetics: american society of clinical oncology clinical practice guideline update J. Clin. Oncol. 29 2011 4189 4198
3. L. Celio, S. Frustaci, A. Denaro, A. Buonadonna, A. Ardizzoia, E. Piazza, A. Fabi, A.M. Capobianco, L. Isa, L. Cavanna, A. Bertolini, E. Bichisao, E. Bajetta Italian Trials in Medical Oncology Group Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial Support. Care Cancer 19 2011 1217 1225
4. M. de Boer-Dennert, R. de Wit, P.I.M. Schmitz, J. Djontono, V. von Beurden, G. Stoter, and J. Verweij Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists Br. J. Cancer 76 1997 1055 1061 (Pubitemid 27434663)
5. A.L. Finn, W.C. Hill, I. Tagarro, and L.N. Gever Absorption and tolerability of fentanyl buccal soluble film (FBSF) in patients with cancer in the presence of oral mucositis J. Pain Res. 4 2011 245 251
6. X. Garcia-del-Muro, C. Vadell, G. Pérez Manga, I. Bover, J. Rifá, M. Beltrán, M.M. Barros, J.R. Germá, X. Fabregat, V. Moreno, A. Salvador, and P. Viladiu Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis Eur. J. Cancer 34 1998 193 195 (Pubitemid 28123400)
7. S.M. Grunberg, M. Dugan, H. Muss, M. Wood, S. Burdette-Radoux, T. Weisberg, and M. Siebel Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy Support. Care Cancer 17 2009 589 594
8. S.M. Grunberg, and J.M. Koeller Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis Expert Opin. Pharmacother. 4 2003 2297 2303 (Pubitemid 37541242)
9. S.W. Hill, A.S. Varker, K. Karlage, and P.B. Myrdal Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications J. Manag. Care Pharm. 15 2009 253 261
10. J.P. Ioannidis, P.J. Hesketh, and J. Lau Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-analysis of randomized evidence J. Clin. Oncol. 18 2000 3409 3422
11. V. Kirchner, M. Aapro, J.P. Terrey, and P. Alberto A double-blind crossover study comparing prophylactic intravenous granisetron alone or in combination with dexamethasone as antiemetic treatment in controlling nausea and vomiting associated with chemotherapy Eur. J. Cancer 33 1997 1605 1610 (Pubitemid 28123482)
12. M.G. Kris, R.J. Gralla, L.B. Tyson, R.A. Clark, C. Cirrincione, and S. Groshen Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin J. Clin. Oncol. 7 1989 108 114 (Pubitemid 19089088)
13. M.G. Kris, P.J. Hesketh, M.R. Somerfield, P. Feyer, R. Clark-Snow, J.M. Koeller, G.R. Morrow, L.W. Chinnery, M.J. Chesney, R.J. Gralla, and S.M. Grunberg American society of clinical oncology guideline for antiemetics in oncology: update J. Clin. Oncol. 24 2006 2932 2947 (Pubitemid 46630595)
14. S. Kunte, and P. Tandale Fast dissolving strips: a novel approach for the delivery of verapamil J. Pharm. Bioallied Sci. 2 2010 325 328
15. W.S. Lofters, J.L. Pater, B. Zee, E. Dempsey, D. Walde, J.P. Moquin, K. Wilson, P. Hoskins, R.M. Guevin, S. Verma, R. Navari, J.E. Krook, J. Hainsworth, M. Palmer, and C. Chin Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy J. Clin. Oncol. 15 1997 2966 2973 (Pubitemid 27330025)
16. NCCN Clinical practice guidelines in oncology. Antiemesis. version I.2011, http://www.nccn.org/professionals/physician-gls/pdf/antiemesis.pdf.
17. M. Nishimura, K. Matsuura, T. Tsukioka, H. Yamashita, N. Inagaki, T. Sugiyama, and Y. Itoh In vitro and in vivo characteristics of prochlorperazine oral disintegrating film Int. J. Pharm. 368 2009 98 102
18. I. Olver, W. Paska, A. Depierre, J.F. Seitz, D.J. Stewart, L. Goedhals, B. McQuade, J. McRae, and J.R. Wilkinson A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Ondansetron delayed emesis study group Ann. Oncol. 7 1996 945 952 (Pubitemid 26426270)
19. F. Roila, J. Herrstedt, M. Aapro, R.J. Gralla, L.H. Einhorn, E. Ballatori, E. Bria, R.A. Clark-Snow, B.T. Espersen, P. Feyer, S.M. Grunberg, P.J. Hesketh, K. Jordan, M.G. Kris, E. Maranzano, A. Molassiotis, G. Morrow, I. Olver, B.L. Rapoport, C. Rittenberg, M. Saito, M. Tonato, D. Warr ESMO/MASCC Guidelines Working Group Guideline update for MASCC and ESMO in the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference Ann. Oncol. 21 Suppl 5 2010 v232 v243
20. F. Roila, M. Tonato, F. Cognetti, E. Cortesi, G. Favalli, M. Marangolo, D. Amadori, M.A. Bella, V. Gramazio, and D. Donati Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone J. Clin. Oncol. 9 1991 675 678
21. H. Shimoda, K. Taniguchi, M. Nishimura, K. Matsuura, T. Tsukioka, H. Yamashita, N. Inagaki, K. Hirano, M. Yamamoto, Y. Kinosada, and Y. Itoh Preparation of a fast dissolving oral thin film containing dexamethasone: a possible application to antiemesis during cancer chemotherapy Eur. J. Pharm. Biopharm. 73 2009 361 365
22. N. Vasisht, L.N. Gever, I. Tagarro, and A.L. Finn Single-dose pharmacokinetics of fentanyl buccal soluble film Pain Med. 11 2010 1017 1023